Efficacy and Safety of Early-Start Deferiprone in Infants and Young Children With Transfusion-Dependent Beta Thalassemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START)
Am. J. Hematol 2023 Jul 04;[EPub Ahead of Print], MS Elalfy, M Hamdy, A Adly, FSE Ebeid, NT Temin, A Rozova, D Lee, C Fradette, F TrictaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.